| DC Field | Value | Language |
|---|
| dc.contributor.author | Dodokhova, M. A. | - |
| dc.contributor.author | Safronenko, A. V. | - |
| dc.contributor.author | Kotieva, I. M. | - |
| dc.contributor.author | Alkhuseyn-Kulyaginova, M. S. | - |
| dc.contributor.author | Shpakovsky, D. B. | - |
| dc.date.accessioned | 2022-05-11T11:50:16Z | - |
| dc.date.available | 2022-05-11T11:50:16Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | Impact of organotin compounds on the growth of epidermoid Lewis carcinoma / M.A. Dodokhova [et al.] // Research Results in Pharmacology. - 2021. - Vol.7, №4.-P. 81-88. - Doi: 10.3897/rrpharmacology.7.71455. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46659 | - |
| dc.description.abstract | Search for new compounds with a broad antitumor and antimetastatic potency due to multiple targeting remains important in medicinal chemistry, pharmacology and oncology. We report the efficacy of hybrid organotin agents bis-(3,5-di-tert-butyl-4-hydroxyphenylthiolate) dimethyltin (Ме3) and (3,5-di-tert-butyl-4-hydroxyphenylthiolate) triphenyltin (Ме5) | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | organotin compounds | ru |
| dc.subject | anticancer drugs | ru |
| dc.subject | epidermoid Lewis lung carcinoma | ru |
| dc.subject | antioxidants | ru |
| dc.title | Impact of organotin compounds on the growth of epidermoid Lewis carcinoma | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 7, № 4
|
